tiprankstipranks
Caulis, Inc. (JP:153A)
:153A
Japanese Market

Caulis, Inc. (153A) AI Stock Analysis

0 Followers

Top Page

JP:153A

Caulis, Inc.

(153A)

Select Model
Select Model
Select Model
Outperform 77 (OpenAI - 5.2)
Rating:77Outperform
Price Target:
¥1,444.00
▼(-32.17% Downside)
Action:ReiteratedDate:04/08/26
The score is driven primarily by strong financial performance (rapid growth, solid margins, and a significantly de-risked balance sheet). Technicals are supportive with positive momentum and price above key short-to-mid-term moving averages, though longer-term trend remains weaker versus the 200-day average and Stoch is elevated. Valuation is a modest headwind due to a higher P/E and low dividend yield.
Positive Factors
Revenue Acceleration
A >100% revenue acceleration in 2025 signals durable demand expansion and successful market penetration. Sustained top-line growth improves operating leverage potential, funds product investment and customer acquisition, and creates a larger base to absorb costs, bolstering long-term earnings resilience.
Negative Factors
Margin Compression
Margins have compressed versus 2022–2024, suggesting rising costs or pricing pressure as the business scales. If structural (input inflation, tougher pricing competition), sustained compression can erode operating leverage, limit reinvestment, and constrain long-term profitability without efficiency gains.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Acceleration
A >100% revenue acceleration in 2025 signals durable demand expansion and successful market penetration. Sustained top-line growth improves operating leverage potential, funds product investment and customer acquisition, and creates a larger base to absorb costs, bolstering long-term earnings resilience.
Read all positive factors

Caulis, Inc. (153A) vs. iShares MSCI Japan ETF (EWJ)

Caulis, Inc. Business Overview & Revenue Model

Company Description
Caulis, Inc. (153A) is a biotechnology company specializing in the development of innovative agricultural solutions and biopesticides aimed at enhancing crop productivity and sustainability. The company focuses on harnessing natural plant-based co...
How the Company Makes Money
null...

Caulis, Inc. Financial Statement Overview

Summary
Strong fundamentals overall: rapid revenue acceleration in 2025 (~108.9%) with solid profitability (2025 gross margin ~58%, operating margin ~29%, net margin ~20%) and a materially improved balance sheet (debt-to-equity ~0.06 in 2025). Main offsets are margin compression vs. 2022–2024 and softer/volatile operating cash flow and cash conversion in recent periods.
Income Statement
86
Very Positive
Balance Sheet
83
Very Positive
Cash Flow
74
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue670.56M1.40B1.23B995.00M769.47M489.21M
Gross Profit422.33M817.28M773.80M611.61M493.95M253.06M
EBITDA224.33M415.15M415.80M300.80M220.91M19.99M
Net Income145.63M276.44M276.30M260.37M249.96M13.46M
Balance Sheet
Total Assets2.21B2.18B2.02B1.18B718.30M481.51M
Cash, Cash Equivalents and Short-Term Investments1.88B1.49B1.73B954.70M604.11M431.24M
Total Debt250.00M100.00M250.00M301.00M250.00M290.00M
Total Liabilities745.17M525.67M708.52M727.04M527.01M538.44M
Stockholders Equity1.47B1.66B1.32B451.66M191.28M-56.93M
Cash Flow
Free Cash Flow0.00205.42M265.90M299.58M212.86M117.33M
Operating Cash Flow0.00208.97M266.22M306.55M215.42M119.36M
Investing Cash Flow0.00-373.80M-322.00K-6.95M-2.56M-2.02M
Financing Cash Flow0.00-81.20M512.50M51.00M-40.00M-2.50M

Caulis, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2129.00
Price Trends
50DMA
1141.54
Positive
100DMA
1246.51
Positive
200DMA
1640.30
Negative
Market Momentum
MACD
55.78
Negative
RSI
58.51
Neutral
STOCH
58.95
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:153A, the sentiment is Positive. The current price of 2129 is above the 20-day moving average (MA) of 1172.65, above the 50-day MA of 1141.54, and above the 200-day MA of 1640.30, indicating a neutral trend. The MACD of 55.78 indicates Negative momentum. The RSI at 58.51 is Neutral, neither overbought nor oversold. The STOCH value of 58.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:153A.

Caulis, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
¥8.51B33.0914.92%2.55%
74
Outperform
¥6.53B21.400.57%21.03%32.29%
67
Neutral
¥8.90B11.670.70%9.78%-23.98%
66
Neutral
¥4.84B21.997.60%19.13%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
60
Neutral
¥6.74B27.1511.32%
55
Neutral
¥4.73B29.814.36%-0.02%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:153A
Caulis, Inc.
1,303.00
428.43
48.99%
JP:4060
rakumo Inc.
1,121.00
323.24
40.52%
JP:4168
Yappli, Inc.
685.00
21.65
3.26%
JP:4397
TeamSpirit, Inc.
408.00
-46.00
-10.13%
JP:4484
Lancers, Inc.
291.00
112.18
62.73%
JP:5033
Nulab Inc.
747.00
-250.00
-25.08%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 08, 2026